Cargando…
FGF signal is not required for hepatoblast differentiation of human iPS cells
Human induced pluripotent stem cell-derived hepatocyte-like cells are expected to be utilized in pharmaceutical research and regenerative medicine. In general, human induced pluripotent stem (iPS) cells are differentiated into hepatocyte-like cells through definitive endoderm cells and hepatoblast-l...
Autores principales: | Toba, Yukiko, Kiso, Ayumi, Nakamae, Souichiro, Sakurai, Fuminori, Takayama, Kazuo, Mizuguchi, Hiroyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6403225/ https://www.ncbi.nlm.nih.gov/pubmed/30842525 http://dx.doi.org/10.1038/s41598-019-40305-2 |
Ejemplares similares
-
Long-Term Self-Renewal of Human ES/iPS-Derived Hepatoblast-like Cells on Human Laminin 111-Coated Dishes
por: Takayama, Kazuo, et al.
Publicado: (2013) -
Efficient Generation of Hepatoblasts From Human ES Cells and iPS Cells by Transient Overexpression of Homeobox Gene HEX
por: Inamura, Mitsuru, et al.
Publicado: (2011) -
Development of a method of passaging and freezing human iPS cell-derived hepatocytes to improve their functions
por: Inui, Jumpei, et al.
Publicado: (2023) -
Human iPS Cell–based Liver-like Tissue Engineering at Extrahepatic Sites in Mice as a New Cell Therapy for Hemophilia B
por: Okamoto, Ryota, et al.
Publicado: (2018) -
Highly efficient biallelic genome editing of human ES/iPS cells using a CRISPR/Cas9 or TALEN system
por: Takayama, Kazuo, et al.
Publicado: (2017)